Deciphera Pharmaceuticals Inc expected to post a loss of 56 cents a share - Earnings Preview

Deciphera Pharmaceuticals

03/02/2023 14:08

* Deciphera Pharmaceuticals Inc  DCPH.OQ   DCPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
February 7. 
    * The Waltham Massachusetts-based  company is expected to
report 
a 47.7% increase in revenue to $35.748 million from $24.2
million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Deciphera
Pharmaceuticals
Inc is for a loss of 56 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $23​, above​ its last closing price
of $17.55. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.57       -0.58      -0.55     Beat    4.6
 Jun. 30 2022  -0.65       -0.66      -0.60     Beat    8.8
 Mar. 31 2022  -0.94       -0.90      -0.80     Beat    11.2​
 Dec. 31 2021  -1.49       -1.38      -1.51     Missed  -9.5
 ​​Sep.        -1.27       -1.28      -1.37     Missed  -7.4
 30 2021                                                
 Jun. 30 2021  -1.16       -1.15      -1.21     Missed  -4.8​
 Mar. 31 2021  -1.07       -1.06      -1.06     Met     0.3
 Dec. 31 2020  -1.15       -1.15      -1.10     Beat    4.5
 This summary was machine generated February 3 at 14:08 GMT.  All
figures in US dollars  unless otherwise stated